Regular readers will recall that Prasad also "resigned" -- and then "UN-resigned", returning to the agency after a Laura Loomer attack -- one that was backed by Tangerine 2.0.
Then, apparently, some staffers told the Manchurian Cantaloupe that praising Democratic office holders might be a useful thing to point to, when Trump is accused of partisan retribution -- especially in "no fire" positions. So, Prasad was given his seat back. In the mean time, Dr. Tidmarsh had signed on, out of Stanford. Now these two boys are. . . feuding.
I will only observe that, at least in the current Tidmarsh kerfluffle. . . this isn't just smoke. . . It. Is. Fire. He was actually trying to garner personal financial benefits [in the form of payments, under a 40 year(!) consulting contract] from a business in which a rival was a large investor, after Tidmarsh had very publicly criticized the business's drug candidate, all while in charge of new drugs -- at FDA. Now he wants back in, ostensibly to "clear his name":
. . .Tidmarsh has claimed that CBER Director Vinay Prasad has targeted him and tried to push him out. Tidmarsh is also facing a lawsuit, and a related investigation inside HHS, claiming he abused his position to try and punish a former business associate with whom he had a falling out.
The episode over the last 24 hours is the latest at an FDA that has been consumed by job cuts, high-profile incidents by top leaders and controversial scientific decisions, casting a pall over the agency’s operations. . . .
[About a year ago Trump's appointment (via Kennedy), of Vinay] Prasad [to lead FDA's CDER] had been greeted negatively by the biotech industry, in part because of his past criticisms of a lack of evidence supporting the approval of some new drugs, as well as his frequent -- and sometimes caustic -- online critiques of drugs, studies and past FDA decisions. . . .
Even so, Prasad had not issued such public critiques (in all cases, these were not backed by any real scientific evidence) while he was in the seat at FDA. That is, by his own admission, what Dr. Tidmarsh has done. Yikes. Chaos certainly is this bunch's central brand. Yikes and. . . boing.
नमस्ते
No comments:
Post a Comment